(2002) Global strategy for asthma management and prevention: National Heart, Lung, and Blood Institute, National Institutes of Health

(2002) Pathogenesis and epidemiology. Asthma and Allergic diseases. The Korean academy of asthma, allergy and clinical immunology., Korea p

(2005) The Korean academy of asthma, allergy and clinical immunology,

(2004) Can guideline-defined asthma control be achieved,

(1997) Effect of inhaled formoterol and budesonide on exacerbations of asthma,

(2001) Low dose inhaled budesonide and formoterol in mild persistent asthma,

(2001) Improved asthma comtrol with budesonide/formoterol in a single inhaler compared with budesonide alone,

(2005) Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma,

(2005) Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?,

(2005) The CONCEPT trial: a 1-year, multicenter, randomized, double-blined, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma,

(2005) Perspective and potential treatment of asthma In update in chronic airway diseases and clinical lung diseases, Respiratory research center. Catholic university of Korea.

(2005) Roflumilast inhibition of pulmonary leukotriene production and brouchoconstriction in ovalbumin-sensitized and -challenged Guinea pigs,

(2006) Comparison of roflumilast with beclomethasone dipropionate in the treatment of persistent asthma,

(2002) Effect of dopamine receptor agonists on sensory nerve activity possible therapeutic targets for the treatment of asthma and COPD,

(1999) Bronchodilation using combined urodilatin-albuterol adminstration in asthma: a randomized, double-blind, placebo-controlled trial,

(2005) Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma,

(2004) Possibilities in improvement of glucocorticoid treatments in asthma with special reference to loteprednol etabonate,

(1996) Efficacy and tolerability of Icatibant in patients with moderately severe chronic bronchial asthma,

(2001) Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen- induced late-phase airway obstruction in asthma,

(2005) The effect of marimastat of marimastat, a metalloprotease inhibitor, on allergen-induced asthmatic hyper-reacitivity.,

(2005) Allergen immunotherapy. Conventional immunotherapy and perspectives in new immunomodulatory treatment,

(2006) Mechanism of allergen- specific immunotherapy,

(2004) Immunotherapy: 1999-2004,

(2004) Immunomodulation: the future of allergy and asthma treatment,

(2002) From allergen structure to new forms of allergen-specific immunotherapy,

(2001) Bypassing IgE and targeting T cells for specific Immunotherapy of allergy,

(2005) Molecular design of allergy vaccines,

(2005) A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination,

(2004) Adjuvants for allergen immunotherapy: exeperimental results and clinical perspectives,

(2004) Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response,

(2005) monophophoryl lipid A(MPL) promotes allergen-induced immune deviation in favour of Th1 response,

(2004) Efficacy and safety of sublingual immunotherapy,

(2006) T regulatory cells in allergy,

(2005) Dendritic cells activated by cross-linking B7-DC(PD-L2) block inflammatory airway dieases,

(1999) CD28 interactions with either CD80 or CD86 are sufficient to induce allergic airway inflammation in mice,

(2005) The effect of treatment with omalizumab on asthma exacerbations and emergency medical visits in patients with severe persistent asthma,

(2004) Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma,

(2004) Efficacy and safety of a recombinant anti-immunoglobulin E antibody(omalizumab) in severe allergic asthma,

(2001) The effects of an anti-CD4 monoclonal antibody on peripheral blood CD4+ T-cells in asthma,

(2005) Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma,

(2005) Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma,

(2003) Effects of BCG revaccination on asthma,

(2002) Allergen-immunostimulatory oligodeoxyuncleotide conjugate: a novel allergoid for immunotherapy.,

(2003) Effects of SCH55700 a humanized anti-human interleukin-5 antibody, in severe persistent asthma a pilot study,

(2003) Anti-IL-5 treatement reduces deposition of ECM proteins in the bronchial subepithelial basement membrance of mild atopic asthmatics,

(1999) Interleukin-4 receptor in moderate atopic asthma: a phase I/II randomized, placebo-controlled trial,

(2001) The effects of an anti-CD4 monoclonal antibody on peripheral blood CD4+ T-cells in asthma,

(2000) Effects of recombinant human interleukin-12 on eosinophils, airway hyper responsiveness, and the late asthmatic response,

(2002) Eotaxin receptor (CCR3) antagonism in asthma and allergic disease,

(2004) Contribution of eotaxin-1 to eosinophil chemotactic activity of moderate and severe asthmatic sputum,

(2003) The effects of an anti-CDlla mAB on allergen-induced airway responses and airway inflammation in subjects with atopic asthma,

(2003) The effects of an anti-CD11amAb on allergen-induced airway responses and airway inflammation in subjects with atopic asthma,

(2000) Pharmacokinetics and tolerability of an antiangiogenic ribozyme(ANGIOZ YME) in healthy volunteers,